These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30667389)

  • 1. [Inflammatory and neoplastic cholangiopathies.].
    Alvaro D; Bragazzi MC; Ridola L
    Recenti Prog Med; 2018 Dec; 109(12):595-599. PubMed ID: 30667389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
    Pinto C; Giordano DM; Maroni L; Marzioni M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid receptors in the biliary tree: TGR5 in physiology and disease.
    Deutschmann K; Reich M; Klindt C; Dröge C; Spomer L; Häussinger D; Keitel V
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1319-1325. PubMed ID: 28844960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cholangiopathies.
    Lazaridis KN; LaRusso NF
    Mayo Clin Proc; 2015 Jun; 90(6):791-800. PubMed ID: 25957621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma.
    Celli A; Que FG
    Semin Liver Dis; 1998; 18(2):177-85. PubMed ID: 9606814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs and benign biliary tract diseases.
    Gradilone SA; O'Hara SP; Masyuk TV; Pisarello MJ; LaRusso NF
    Semin Liver Dis; 2015 Feb; 35(1):26-35. PubMed ID: 25632932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets.
    Grama A; Mititelu A; Sîrbe C; Benţa G; Pop TL
    Front Immunol; 2023; 14():1206025. PubMed ID: 37928553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice.
    Yang Y; Wang J; Wan J; Cheng Q; Cheng Z; Zhou X; Wang O; Shi K; Wang L; Wang B; Zhu X; Chen J; Feng D; Liu Y; Jahan-Mihan Y; Haddock AN; Edenfield BH; Peng G; Hohenstein JD; McCabe CE; O'Brien DR; Wang C; Ilyas SI; Jiang L; Torbenson MS; Wang H; Nakhleh RE; Shi X; Wang Y; Bi Y; Gores GJ; Patel T; Ji B
    J Hepatol; 2024 Jul; 81(1):120-134. PubMed ID: 38428643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights on the molecular and cell biology of human cholangiopathies.
    Alvaro D; Mancino MG
    Mol Aspects Med; 2008; 29(1-2):50-7. PubMed ID: 18230407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of cholestasis: An update on inflammatory cholangiopathies.
    Mariotti V; Cadamuro M; Spirli C; Fiorotto R; Strazzabosco M; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):954-964. PubMed ID: 30398152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma.
    Nguyen Canh H; Harada K
    Med Mol Morphol; 2016 Dec; 49(4):189-202. PubMed ID: 27350291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
    Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic Cholangiocarcinoma.
    El-Diwany R; Pawlik TM; Ejaz A
    Surg Oncol Clin N Am; 2019 Oct; 28(4):587-599. PubMed ID: 31472907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiologic and pathologic experimental models for studying cholangiocytes].
    Lee SO
    Korean J Hepatol; 2008 Jun; 14(2):139-49. PubMed ID: 18617761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
    Pollheimer MJ; Fickert P; Stieger B
    Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation.
    Cheifetz RE; Davis NL; Owen DA
    Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.
    Esparza-Baquer A; Labiano I; Bujanda L; Perugorria MJ; Banales JM
    Clin Res Hepatol Gastroenterol; 2016 Feb; 40(1):15-27. PubMed ID: 26774196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
    Taghavi SA; Eshraghian A; Niknam R; Sivandzadeh GR; Bagheri Lankarani K
    Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):575-584. PubMed ID: 29781738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.